Literature DB >> 6971969

Suppression of normal granulopoiesis in vitro by a leukemia associated inhibitor (LAI) derived from a human promyelocytic cell line [HL-60].

T Olofsson, I Olsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6971969     DOI： 10.1016/0145-2126(80)90026-0

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  6 in total

1.  Structure and expression of ferritin genes in a human promyelocytic cell line that differentiates in vitro.

Authors:  C C Chou; R A Gatti; M L Fuller; P Concannon; A Wong; S Chada; R C Davis; W A Salser
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

2.  Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias.

Authors:  I Olsson; T Olofsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

3.  Neutralization of inhibitory activity derived from cells of MDS patients and ML-2 cell line by monoclonal antibodies against H and L-subunit-rich ferritins.

Authors:  V Cukrová; R Neuwirtová
Journal:  Blut       Date:  1990-11

4.  Leukocyte-derived inhibitory activity in patients with myelodysplastic syndrome.

Authors:  V Cukrová; R Neuwirtová; J Cermák; V Malasková; J Neuwirt
Journal:  Blut       Date:  1987-09

5.  Identification of leukemia cell-derived inhibitory activity (LIA) in conditioned media from human myeloid leukemic cell line ML-2.

Authors:  V Cukrová; Z Hrkal; H Koprivová; J Neuwirt
Journal:  Blut       Date:  1986-01

6.  Suppression of lymphocyte activation and functions by a leukemia cell-derived inhibitor.

Authors:  J W Chiao; M Heil; Z Arlin; J D Lutton; Y S Choi; K Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.